Quince Therapeutics, Inc. (QNCX) SEC filings
QNCX SEC filings moved a median of 0.00% by the close. QNCX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the QNCX overview →
87 measured QNCX SEC filing events.
Where these QNCX SEC filings landedvs 83 measured QNCX SEC filing reactions
| Middle 50% of QNCX SEC filing reactions | -2.06% to +4.76% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 83 |
Point-in-time · zero look-ahead
Half of the 83 QNCX SEC filing events with a measured close landed between -2.06% and +4.76%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Quince Therapeutics, For: Oct 07 | SEC filing · Form 8-K | +1.31% | +4.03% | |
| Form S-8 Quince Therapeutics, | SEC filing · Form S-8 | +1.31% | +4.03% | |
| Form 8-K Quince Therapeutics, For: Oct 06 | SEC filing · Form 8-K | +0.00% | -0.07% | |
| Form 8-K Quince Therapeutics, For: Sep 30 | SEC filing · Form 8-K | +0.37% | -2.96% | |
| Form DEFA14A Quince Therapeutics, | SEC filing · Form DEFA14A | +0.37% | -2.96% | |
| Form 8-K Quince Therapeutics, For: Sep 08 | SEC filing · Form 8-K | +0.00% | +0.96% | |
| Form 8-K Quince Therapeutics, For: Aug 31 | SEC filing · Form 8-K | +0.03% | +2.59% | |
| Form 8-K Quince Therapeutics, For: Aug 23 | SEC filing · Form 8-K | -0.33% | +2.55% | |
| Form DEF 14A Quince Therapeutics, For: Oct 06 | SEC filing · Form DEF | +0.00% | -4.54% | |
| Form EFFECT Quince Therapeutics, | SEC filing · Form EFFECT | +0.00% | -4.54% | |
| Form 8-K Quince Therapeutics, For: Aug 17 | SEC filing · Form 8-K | +0.00% | -2.38% | |
| Form 10-Q Quince Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.38% | |
| Form 8-K Quince Therapeutics, For: Aug 14 | SEC filing · Form 8-K | +5.32% | +7.11% | |
| Form S-3/A Quince Therapeutics, | SEC filing · Form S-3 | +0.00% | +6.33% | |
| Form 8-K Quince Therapeutics, For: Jul 29 | SEC filing · Form 8-K | +0.00% | +4.81% | |
| Form PRE 14A Quince Therapeutics, For: Jul 31 | SEC filing · Form PRE | +0.00% | +4.81% | |
| Form S-3 Quince Therapeutics, | SEC filing · Form S-3 | +0.00% | +4.81% | |
| Form 8-K/A Quince Therapeutics, For: May 17 | SEC filing · Form 8-K | +0.87% | +5.59% | |
| Form 8-K Quince Therapeutics, For: Jun 26 | SEC filing · Form 8-K | -0.03% | -0.35% | |
| Form 8-K/A Quince Therapeutics, For: Jun 26 | SEC filing · Form 8-K | -1.05% | -1.01% | |
| Form 8-K Quince Therapeutics, For: Jun 11 | SEC filing · Form 8-K | +3.74% | -0.65% | |
| Form D Quince Therapeutics, | SEC filing · Form D | +0.12% | +5.15% | |
| Form 8-K Quince Therapeutics, For: May 20 | SEC filing · Form 8-K | +3.08% | +5.77% | |
| Form 8-K Quince Therapeutics, For: May 17 | SEC filing · Form 8-K | +5.26% | +4.72% | |
| Form 8-K/A Quince Therapeutics, For: May 17 | SEC filing · Form 8-K | -3.75% | +2.88% | |
| Form 10-Q Quince Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.41% | +3.28% | |
| Form 8-K Quince Therapeutics, For: Apr 27 | SEC filing · Form 8-K | +0.81% | -0.81% | |
| Form ARS Quince Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.26% | -1.60% | |
| Form DEF 14A Quince Therapeutics, For: Jun 11 | SEC filing · Form DEF | -1.26% | -1.60% | |
| Form DEFA14A Quince Therapeutics, | SEC filing · Form DEFA14A | -1.26% | -1.60% | |
| Form 8-K Quince Therapeutics, For: Apr 22 | SEC filing · Form 8-K | +4.75% | -0.73% | |
| Form PRE 14A Quince Therapeutics, For: Jun 11 | SEC filing · Form PRE | +2.80% | +1.60% | |
| Form S-8 Quince Therapeutics, | SEC filing · Form S-8 | +2.80% | +1.60% | |
| Form 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.88% | +9.30% | |
| Form 8-K Quince Therapeutics, For: Apr 09 | SEC filing · Form 8-K | +3.26% | -1.67% | |
| Form NT 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form NT | -5.40% | -1.00% | |
| Form 8-K Quince Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -7.94% | -9.63% | |
| Form 8-K Quince Therapeutics, For: Mar 16 | SEC filing · Form 8-K | -1.52% | +18.83% | |
| Form 8-K Quince Therapeutics, For: Feb 12 | SEC filing · Form 8-K | -1.78% | -42.18% | |
| Form 8-K Quince Therapeutics, For: Jan 30 | SEC filing · Form 8-K | -5.85% | -20.55% | |
| Form 8-K Quince Therapeutics, For: Jan 29 | SEC filing · Form 8-K | -13.12% | -32.00% | |
| Form 10-Q Quince Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.63% | — | |
| Form 8-K Quince Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -2.63% | — | |
| Form 8-K Quince Therapeutics, For: Oct 17 | SEC filing · Form 8-K | -0.54% | +0.54% | |
| Form 8-K Quince Therapeutics, For: Sep 25 | SEC filing · Form 8-K | +0.97% | +0.00% | |
| Form 10-Q Quince Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 8-K Quince Therapeutics, For: Aug 11 | SEC filing · Form 8-K | +0.00% | — | |
| Form EFFECT Quince Therapeutics, | SEC filing · Form EFFECT | -1.20% | -0.60% | |
| Form S-3 Quince Therapeutics, | SEC filing · Form S-3 | -1.93% | -3.74% | |
| Form 8-K Quince Therapeutics, For: Jul 16 | SEC filing · Form 8-K | +1.21% | +10.91% | |
| Form D Quince Therapeutics, | SEC filing · Form D | -0.64% | -1.29% | |
| Form 8-K Quince Therapeutics, For: Jun 12 | SEC filing · Form 8-K | -2.08% | -4.17% | |
| Form 8-K Quince Therapeutics, For: Jun 04 | SEC filing · Form 8-K | +0.28% | -2.50% | |
| Form 10-Q Quince Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.98% | -6.86% | |
| Form 8-K Quince Therapeutics, For: May 13 | SEC filing · Form 8-K | -0.98% | -6.86% | |
| Form ARS Quince Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +6.13% | |
| Form DEF 14A Quince Therapeutics, For: Jun 04 | SEC filing · Form DEF | +0.00% | +6.13% | |
| Form DEFA14A Quince Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +6.13% | |
| Form PRE 14A Quince Therapeutics, For: Dec 31 | SEC filing · Form PRE | -1.03% | +1.73% | |
| Form 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.21% | +0.73% | |
| Form 8-K Quince Therapeutics, For: Mar 24 | SEC filing · Form 8-K | +2.21% | +0.73% | |
| Form S-8 Quince Therapeutics, | SEC filing · Form S-8 | +2.21% | +0.73% | |
| Form EFFECT Quince Therapeutics, | SEC filing · Form EFFECT | -0.32% | +10.29% | |
| Form S-3 Quince Therapeutics, | SEC filing · Form S-3 | +2.16% | -4.87% | |
| Form 8-K Quince Therapeutics, For: Nov 12 | SEC filing · Form 8-K | +4.49% | +21.80% | |
| Form 10-Q Quince Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +4.49% | +21.80% | |
| Form 8-K Quince Therapeutics, For: Nov 13 | SEC filing · Form 8-K | +4.49% | +21.80% | |
| Form 10-Q Quince Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +3.45% | -5.22% | |
| Form 8-K Quince Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +3.45% | -5.22% | |
| Form 8-K Quince Therapeutics, For: Jun 20 | SEC filing · Form 8-K | +0.16% | +0.87% | |
| Form 8-K Quince Therapeutics, For: Jun 05 | SEC filing · Form 8-K | -1.51% | -3.55% | |
| Form 10-Q Quince Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.20% | |
| Form ARS Quince Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +0.00% | |
| Form DEF 14A Quince Therapeutics, For: Jun 05 | SEC filing · Form DEF | +0.00% | +0.00% | |
| Form DEFA14A Quince Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +0.00% | |
| Form PRE 14A Quince Therapeutics, For: Jun 05 | SEC filing · Form PRE | -2.06% | -2.79% | |
| Form 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.94% | |
| Form S-8 Quince Therapeutics, | SEC filing · Form S-8 | +0.00% | -0.94% | |
| Form 8-K Quince Therapeutics, For: Feb 13 | SEC filing · Form 8-K | +0.00% | -1.54% | |
| Form 8-K Quince Therapeutics, For: Jan 23 | SEC filing · Form 8-K | +3.47% | +7.76% | |
| Form 8-K/A Quince Therapeutics, For: Oct 20 | SEC filing · Form 8-K | +1.75% | -1.75% | |
| Form 8-K Quince Therapeutics, For: Dec 29 | SEC filing · Form 8-K | +0.00% | +7.62% | |
| Form 8-K Quince Therapeutics, For: Dec 22 | SEC filing · Form 8-K | +0.88% | +0.00% | |
| Form 8-K Quince Therapeutics, For: Dec 04 | SEC filing · Form 8-K | +4.21% | +5.26% | |
| Form 10-Q Quince Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.29% | -1.11% | |
| Form 8-K Quince Therapeutics, For: Oct 24 | SEC filing · Form 8-K | +0.00% | -2.99% | |
| Form 8-K Quince Therapeutics, For: Oct 20 | SEC filing · Form 8-K | +0.00% | +1.20% |
Keep exploring
More QNCX: earnings → · analyst actions → · QNCX overview →